tirzepatide from lilly FDA approves tirzepatide, Eli Lilly's new type 2 diabetes drug, and the company shares an estimated price Lilly gets FDA okay for

Smriti Choudhary, MD, and his skilled team assist patients in reaching their weight reduction objectives

Immunotherapy Immunotherapy is a treatment that uses the patients immune system to fight cancer

A recent JAMA Cardiology (2026) analysis from the SOUL randomized clinical trial highlights an important shift: Oral semaglutide (a GLP-1 receptor agonist) significantly improved cardiovascular risk factors in high-risk patients with type 2 diabetes

A medical provider explains what peptides are, what they treat, how supervised therapy works, safety, cost, and how to start in Doral

There is no single best weight loss peptide for every research application